without being an expert here … this looks like a drug with similar modality, similar market size, similar drug pricing .. and at same development stage as Rp 11
…. and I think our other eye drugs in development/testing may be even bigger!
surely must be a deal to be done soon by PYC on Rp 11
that Ionis deal was - $280 million upfront - $660 million in milestone payments - 15% royalty on sales
what would that do to the PYC share price ??
The kidney cyst drug would be fully funded to market
PYC Price at posting:
$1.30 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)